Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Novel Biomarkers in Chronic Airway Diseases

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified February 2009 by Chonbuk National University.
Recruitment status was:  Recruiting
Information provided by:
Chonbuk National University Identifier:
First received: February 23, 2009
Last updated: NA
Last verified: February 2009
History: No changes posted

The purpose of this study is:

  • To define The differences of bio-chemical phenotypes in chronic airway inflammatory diseases.
  • To identify novel biomarkers in chronic airway inflammatory diseases as a screening, diagnostic, or monitoring marker.


Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: The Study for The Identification of Novel Biomarkers in Chronic Airway Inflammatory Disorders

Further study details as provided by Chonbuk National University:

Estimated Enrollment: 30
Study Start Date: February 2009
Estimated Study Completion Date: January 2010
Acute exacerbation
Stable disease
Healthy control


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Patients with acute exacerbation of asthma or COPD, patients with stable status of those disease, and the healthy control subjects

Inclusion Criteria:

  • > 18 years olds
  • Both sexes
  • Asthma or COPD was diagnosed according to the criteria of the American Thoracic Society, GINA, GOLD guideline
  • Acute exacerbation was defined by the criteria of the American Thoracic Society, GINA, GOLD guideline
  • For stable disease, none of the subjects had received inhaled or oral corticosteroids or any other anti-inflammatory drugs, had an exacerbation history in the previous 6 months
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00849836

Contact: So Ri Kim, MD, PhD 82-63-250-2475
Contact: Yong Chul Lee, MD, PhD 82-63-250-1664

Korea, Republic of
Chonbuk National University Medical School Recruiting
Jeonju, Korea, Republic of, 561-180
Contact: So Ri Kim, MD, PhD   
Contact: Yong Chul Lee, MD, PhD   
Principal Investigator: Yong Chul Lee, MD, PhD         
Sub-Investigator: So Ri Kim, MD, PhD         
Sponsors and Collaborators
Chonbuk National University
  More Information

Responsible Party: Yong Chul Lee, Chonbuk National University Medical School Identifier: NCT00849836     History of Changes
Other Study ID Numbers: RCPD
Study First Received: February 23, 2009
Last Updated: February 23, 2009 processed this record on May 25, 2017